Aerosolization of viable <i>Mycobacterium tuberculosis</i> bacilli by tuberculosis clinic attendees independent of sputum-Xpert Ultra status. Patterson, B., Dinkele, R., Gessner, S., Koch, A., Hoosen, Z., January, V., Leonard, B., McKerry, A., Seldon, R., Vazi, A., Hermans, S., Cobelens, F., Warner, D. F, & Wood, R. Proceedings of the National Academy of Sciences, 121(12):e2314813121, Proceedings of the National Academy of Sciences, mar, 2024. ![Aerosolization of viable <i>Mycobacterium tuberculosis</i> bacilli by tuberculosis clinic attendees independent of sputum-Xpert Ultra status [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex Potential Mycobacterium tuberculosis ( Mtb ) transmission during different pulmonary tuberculosis (TB) disease states is poorly understood. We quantified viable aerosolized Mtb from TB clinic attendees following diagnosis and through six months' follow-up thereafter. Presumptive TB patients (n=102) were classified by laboratory, radiological, and clinical features into Group A: Sputum-Xpert Ultra-positive TB (n=52), Group B: Sputum-Xpert Ultra-negative TB (n=20), or Group C: TB undiagnosed (n=30). All groups were assessed for Mtb bioaerosol release at baseline, and subsequently at 2 wk, 2 mo, and 6 mo. Groups A and B were notified to the national TB program and received standard anti-TB chemotherapy; Mtb was isolated from 92% and 90% at presentation, 87% and 74% at 2 wk, 54% and 44% at 2 mo and 32% and 20% at 6 mo, respectively. Surprisingly, similar numbers were detected in Group C not initiating TB treatment: 93%, 70%, 48% and 22% at the same timepoints. A temporal association was observed between Mtb bioaerosol release and TB symptoms in all three groups. Persistence of Mtb bioaerosol positivity was observed in \ 30% of participants irrespective of TB chemotherapy. Captured Mtb bacilli were predominantly acid-fast stain-negative and poorly culturable; however, three bioaerosol samples yielded sufficient biomass following culture for whole-genome sequencing, revealing two different Mtb lineages. Detection of viable aerosolized Mtb in clinic attendees, independent of TB diagnosis, suggests that unidentified Mtb transmitters might contribute a significant attributable proportion of community exposure. Additional longitudinal studies with sputum culture-positive and -negative control participants are required to investigate this possibility.
@article{Patterson2024,
abstract = {Potential Mycobacterium tuberculosis ( Mtb ) transmission during different pulmonary tuberculosis (TB) disease states is poorly understood. We quantified viable aerosolized Mtb from TB clinic attendees following diagnosis and through six months' follow-up thereafter. Presumptive TB patients (n=102) were classified by laboratory, radiological, and clinical features into Group A: Sputum-Xpert Ultra-positive TB (n=52), Group B: Sputum-Xpert Ultra-negative TB (n=20), or Group C: TB undiagnosed (n=30). All groups were assessed for Mtb bioaerosol release at baseline, and subsequently at 2 wk, 2 mo, and 6 mo. Groups A and B were notified to the national TB program and received standard anti-TB chemotherapy; Mtb was isolated from 92{\%} and 90{\%} at presentation, 87{\%} and 74{\%} at 2 wk, 54{\%} and 44{\%} at 2 mo and 32{\%} and 20{\%} at 6 mo, respectively. Surprisingly, similar numbers were detected in Group C not initiating TB treatment: 93{\%}, 70{\%}, 48{\%} and 22{\%} at the same timepoints. A temporal association was observed between Mtb bioaerosol release and TB symptoms in all three groups. Persistence of Mtb bioaerosol positivity was observed in {\~{}}30{\%} of participants irrespective of TB chemotherapy. Captured Mtb bacilli were predominantly acid-fast stain-negative and poorly culturable; however, three bioaerosol samples yielded sufficient biomass following culture for whole-genome sequencing, revealing two different Mtb lineages. Detection of viable aerosolized Mtb in clinic attendees, independent of TB diagnosis, suggests that unidentified Mtb transmitters might contribute a significant attributable proportion of community exposure. Additional longitudinal studies with sputum culture-positive and -negative control participants are required to investigate this possibility.},
author = {Patterson, Benjamin and Dinkele, Ryan and Gessner, Sophia and Koch, Anastasia and Hoosen, Zeenat and January, Vanessa and Leonard, Bryan and McKerry, Andrea and Seldon, Ronnett and Vazi, Andiswa and Hermans, Sabine and Cobelens, Frank and Warner, Digby F and Wood, Robin},
doi = {10.1073/PNAS.2314813121/SUPPL_FILE/PNAS.2314813121.SAPP.PDF},
file = {:C$\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Patterson et al. - 2024 - Aerosolization of viable Mycobacterium tuberculosis bacilli by tuberculosis clinic attendees independent of sp.pdf:pdf},
issn = {0027-8424},
journal = {Proceedings of the National Academy of Sciences},
keywords = {OA,aerosol sampling,fund{\_}not{\_}ack,original,subclinical,tuberculosis},
mendeley-tags = {OA,fund{\_}not{\_}ack,original},
month = {mar},
number = {12},
pages = {e2314813121},
pmid = {38470917},
publisher = {Proceedings of the National Academy of Sciences},
title = {{Aerosolization of viable \textit{Mycobacterium tuberculosis} bacilli by tuberculosis clinic attendees independent of sputum-Xpert Ultra status}},
url = {https://www.pnas.org/doi/abs/10.1073/pnas.2314813121},
volume = {121},
year = {2024}
}
Downloads: 0
{"_id":"5eqt4Su8gYPCieeaz","bibbaseid":"patterson-dinkele-gessner-koch-hoosen-january-leonard-mckerry-etal-aerosolizationofviableimycobacteriumtuberculosisibacillibytuberculosisclinicattendeesindependentofsputumxpertultrastatus-2024","author_short":["Patterson, B.","Dinkele, R.","Gessner, S.","Koch, A.","Hoosen, Z.","January, V.","Leonard, B.","McKerry, A.","Seldon, R.","Vazi, A.","Hermans, S.","Cobelens, F.","Warner, D. F","Wood, R."],"bibdata":{"bibtype":"article","type":"article","abstract":"Potential Mycobacterium tuberculosis ( Mtb ) transmission during different pulmonary tuberculosis (TB) disease states is poorly understood. We quantified viable aerosolized Mtb from TB clinic attendees following diagnosis and through six months' follow-up thereafter. Presumptive TB patients (n=102) were classified by laboratory, radiological, and clinical features into Group A: Sputum-Xpert Ultra-positive TB (n=52), Group B: Sputum-Xpert Ultra-negative TB (n=20), or Group C: TB undiagnosed (n=30). All groups were assessed for Mtb bioaerosol release at baseline, and subsequently at 2 wk, 2 mo, and 6 mo. Groups A and B were notified to the national TB program and received standard anti-TB chemotherapy; Mtb was isolated from 92% and 90% at presentation, 87% and 74% at 2 wk, 54% and 44% at 2 mo and 32% and 20% at 6 mo, respectively. Surprisingly, similar numbers were detected in Group C not initiating TB treatment: 93%, 70%, 48% and 22% at the same timepoints. A temporal association was observed between Mtb bioaerosol release and TB symptoms in all three groups. Persistence of Mtb bioaerosol positivity was observed in \\ 30% of participants irrespective of TB chemotherapy. Captured Mtb bacilli were predominantly acid-fast stain-negative and poorly culturable; however, three bioaerosol samples yielded sufficient biomass following culture for whole-genome sequencing, revealing two different Mtb lineages. Detection of viable aerosolized Mtb in clinic attendees, independent of TB diagnosis, suggests that unidentified Mtb transmitters might contribute a significant attributable proportion of community exposure. Additional longitudinal studies with sputum culture-positive and -negative control participants are required to investigate this possibility.","author":[{"propositions":[],"lastnames":["Patterson"],"firstnames":["Benjamin"],"suffixes":[]},{"propositions":[],"lastnames":["Dinkele"],"firstnames":["Ryan"],"suffixes":[]},{"propositions":[],"lastnames":["Gessner"],"firstnames":["Sophia"],"suffixes":[]},{"propositions":[],"lastnames":["Koch"],"firstnames":["Anastasia"],"suffixes":[]},{"propositions":[],"lastnames":["Hoosen"],"firstnames":["Zeenat"],"suffixes":[]},{"propositions":[],"lastnames":["January"],"firstnames":["Vanessa"],"suffixes":[]},{"propositions":[],"lastnames":["Leonard"],"firstnames":["Bryan"],"suffixes":[]},{"propositions":[],"lastnames":["McKerry"],"firstnames":["Andrea"],"suffixes":[]},{"propositions":[],"lastnames":["Seldon"],"firstnames":["Ronnett"],"suffixes":[]},{"propositions":[],"lastnames":["Vazi"],"firstnames":["Andiswa"],"suffixes":[]},{"propositions":[],"lastnames":["Hermans"],"firstnames":["Sabine"],"suffixes":[]},{"propositions":[],"lastnames":["Cobelens"],"firstnames":["Frank"],"suffixes":[]},{"propositions":[],"lastnames":["Warner"],"firstnames":["Digby","F"],"suffixes":[]},{"propositions":[],"lastnames":["Wood"],"firstnames":["Robin"],"suffixes":[]}],"doi":"10.1073/PNAS.2314813121/SUPPL_FILE/PNAS.2314813121.SAPP.PDF","file":":C$\\$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Patterson et al. - 2024 - Aerosolization of viable Mycobacterium tuberculosis bacilli by tuberculosis clinic attendees independent of sp.pdf:pdf","issn":"0027-8424","journal":"Proceedings of the National Academy of Sciences","keywords":"OA,aerosol sampling,fund_not_ack,original,subclinical,tuberculosis","mendeley-tags":"OA,fund_not_ack,original","month":"mar","number":"12","pages":"e2314813121","pmid":"38470917","publisher":"Proceedings of the National Academy of Sciences","title":"Aerosolization of viable <i>Mycobacterium tuberculosis</i> bacilli by tuberculosis clinic attendees independent of sputum-Xpert Ultra status","url":"https://www.pnas.org/doi/abs/10.1073/pnas.2314813121","volume":"121","year":"2024","bibtex":"@article{Patterson2024,\r\nabstract = {Potential Mycobacterium tuberculosis ( Mtb ) transmission during different pulmonary tuberculosis (TB) disease states is poorly understood. We quantified viable aerosolized Mtb from TB clinic attendees following diagnosis and through six months' follow-up thereafter. Presumptive TB patients (n=102) were classified by laboratory, radiological, and clinical features into Group A: Sputum-Xpert Ultra-positive TB (n=52), Group B: Sputum-Xpert Ultra-negative TB (n=20), or Group C: TB undiagnosed (n=30). All groups were assessed for Mtb bioaerosol release at baseline, and subsequently at 2 wk, 2 mo, and 6 mo. Groups A and B were notified to the national TB program and received standard anti-TB chemotherapy; Mtb was isolated from 92{\\%} and 90{\\%} at presentation, 87{\\%} and 74{\\%} at 2 wk, 54{\\%} and 44{\\%} at 2 mo and 32{\\%} and 20{\\%} at 6 mo, respectively. Surprisingly, similar numbers were detected in Group C not initiating TB treatment: 93{\\%}, 70{\\%}, 48{\\%} and 22{\\%} at the same timepoints. A temporal association was observed between Mtb bioaerosol release and TB symptoms in all three groups. Persistence of Mtb bioaerosol positivity was observed in {\\~{}}30{\\%} of participants irrespective of TB chemotherapy. Captured Mtb bacilli were predominantly acid-fast stain-negative and poorly culturable; however, three bioaerosol samples yielded sufficient biomass following culture for whole-genome sequencing, revealing two different Mtb lineages. Detection of viable aerosolized Mtb in clinic attendees, independent of TB diagnosis, suggests that unidentified Mtb transmitters might contribute a significant attributable proportion of community exposure. Additional longitudinal studies with sputum culture-positive and -negative control participants are required to investigate this possibility.},\r\nauthor = {Patterson, Benjamin and Dinkele, Ryan and Gessner, Sophia and Koch, Anastasia and Hoosen, Zeenat and January, Vanessa and Leonard, Bryan and McKerry, Andrea and Seldon, Ronnett and Vazi, Andiswa and Hermans, Sabine and Cobelens, Frank and Warner, Digby F and Wood, Robin},\r\ndoi = {10.1073/PNAS.2314813121/SUPPL_FILE/PNAS.2314813121.SAPP.PDF},\r\nfile = {:C$\\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Patterson et al. - 2024 - Aerosolization of viable Mycobacterium tuberculosis bacilli by tuberculosis clinic attendees independent of sp.pdf:pdf},\r\nissn = {0027-8424},\r\njournal = {Proceedings of the National Academy of Sciences},\r\nkeywords = {OA,aerosol sampling,fund{\\_}not{\\_}ack,original,subclinical,tuberculosis},\r\nmendeley-tags = {OA,fund{\\_}not{\\_}ack,original},\r\nmonth = {mar},\r\nnumber = {12},\r\npages = {e2314813121},\r\npmid = {38470917},\r\npublisher = {Proceedings of the National Academy of Sciences},\r\ntitle = {{Aerosolization of viable \\textit{Mycobacterium tuberculosis} bacilli by tuberculosis clinic attendees independent of sputum-Xpert Ultra status}},\r\nurl = {https://www.pnas.org/doi/abs/10.1073/pnas.2314813121},\r\nvolume = {121},\r\nyear = {2024}\r\n}\r\n","author_short":["Patterson, B.","Dinkele, R.","Gessner, S.","Koch, A.","Hoosen, Z.","January, V.","Leonard, B.","McKerry, A.","Seldon, R.","Vazi, A.","Hermans, S.","Cobelens, F.","Warner, D. F","Wood, R."],"key":"Patterson2024","id":"Patterson2024","bibbaseid":"patterson-dinkele-gessner-koch-hoosen-january-leonard-mckerry-etal-aerosolizationofviableimycobacteriumtuberculosisibacillibytuberculosisclinicattendeesindependentofsputumxpertultrastatus-2024","role":"author","urls":{"Paper":"https://www.pnas.org/doi/abs/10.1073/pnas.2314813121"},"keyword":["OA","aerosol sampling","fund_not_ack","original","subclinical","tuberculosis"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://drive.google.com/uc?export=download&id=1-JLqZ7RwZ3VC2d6ErLGHAtOeMRS_7GCz","dataSources":["Krmt6gt9ktB2s6ARh"],"keywords":["oa","aerosol sampling","fund_not_ack","original","subclinical","tuberculosis"],"search_terms":["aerosolization","viable","mycobacterium","tuberculosis","bacilli","tuberculosis","clinic","attendees","independent","sputum","xpert","ultra","status","patterson","dinkele","gessner","koch","hoosen","january","leonard","mckerry","seldon","vazi","hermans","cobelens","warner","wood"],"title":"Aerosolization of viable <i>Mycobacterium tuberculosis</i> bacilli by tuberculosis clinic attendees independent of sputum-Xpert Ultra status","year":2024}